Around the web
Curing Cancer isn’t good for Big Pharma… - They Write What They're Told, We Don't!

Curing Cancer isn’t good for Big Pharma…

By Carla B.

Follow us: @EOTMPR on Twitter |EOTM.Media on Facebook

The truth of a theory can never be proven; for one never knows if future experience will contradict its conclusions.

-Albert Einstein, 1919

Image result for cancer cells

According to the World Health Organization each year 8.8 million people die from cancer, mostly in low and middle income countries.

Did you know that cancer is one of the most common causes of death in the world today? For instance, the American Cancer Society — in a recent report confirmed that cancer is the second most common cause of death in the US and accounts for nearly 1 of every 4 deaths.

Are you aware that cancer is not hereditary? Not really, in the true sense of the word. Hereditary means that you get a trait such as eye color or an illness from the genes you inherit from your parents. The cause of cancer is not as simple as that.

According to Dr. David Gorski, “cancer is not a single disease, it’s hundreds of diseases, and although there are many common themes in cancer, such as loss of responsiveness to growth signals with a resultant ability to grow unchecked. Other common capabilities of cancer cells include evasion of programmed cell death (apoptosis), inducing the surrounding tissue to provide a blood supply (angiogenesis), evading the immune system, and invading the blood or lymphatic systems to travel elsewhere in the body and take up shop in other organs, such as liver, lung, or bone. Although there are, again, common molecular themes by which cancers do this, individual cancers acquire these necessary (to the cancer) abilities by many different ways.

Even cancers arising from the same cell type can be quite different. For instance, the breast cancer that killed my mother-in-law was a rare spindle cell variant, which is quite different from the much more common invasive ductal carcinoma that is estrogen and progesterone receptor positive. Indeed, even within individual cancers, different populations of cells can be quite different. In many solid tumors, there are cells now referred to as “stem cells.” Personally, I consider this term a bit of a misnomer that I really don’t like because these cells are not really pluripotent, and the cell types into which they can differentiate are rather limited. Moreover, this nomenclature has also made the concept of the cancer stem cell more controversial scientifically than it really needs to be. What we are really talking about are a relatively small population of cells in many tumors that are endlessly self-renewing and, in general, resistant to chemotherapy. In mice, these are the only cells that can actually form a new tumor when transplanted into a new mouse, and these are the cells that appear to be responsible for relapse after chemotherapy and radiation therapy. Indeed, cancer progression can be viewed as being due to a case of evolution in which the tumor cells that survive selection to continue to grow are the ones that become best at doing all the things that tumor cells need to do to evade the body’s defenses and overcome its growth control signals.

Moreover, not only is cancer not a single disease, but individual cancers are made up of multiple different clones of cancer cells under selective pressure to become ever more invasive and deadly. Looking at it this way, it’s a wonder we don’t all die of cancer. We do, however, virtually all have small foci of cancer within us, as I’ve pointed out before. Yet most of us do not develop cancer, and fewer of us end up dying of cancer, even though cancer is currently duking it out with heart disease as the number one cause of death in industrialized societies. Fortunately, the steps required for cancer to become deadly are difficult and numerous, and the body’s defenses against cancer are formidable,” Gorski continued.

Notably, have you ever asked yourself why a cure for cancer has not happened yet? Despite all the breakthrough claims?  It seems like almost every day, we hear about another miraculous advance in cancer treatment and yet, our loved ones keep dying of cancer. What’s up with that? Are greedy drug companies holding back a promising treatment? Would the FDA kill a wonder drug? Have corporate scientists refused to accept new ideas? Your guess is as good as mine.

It’s incredulous how the death rate from cancer hasn’t changed in the past 50 years! And we all sit by and believe this is possible — allowing our family and friends to pass away in the interim….with no other options. No care to even lift a finger to research and discover if there are any options outside of big pharma. I don’t mean to sound cold and judgmental — just trying to get you to see my point which is, there are other options! 

According to Professor and lead cancer researcher Paul Workman, ”it’s very unlikely there will ever be a single ‘cure’ because cancer is made up of more than 200 different diseases – like breast, lung, bowel, prostate and blood cancers – and the latest molecular research is breaking these classes down into many more sub-groups. Different targeted treatments are needed for each sub-type – an approach called ‘personalized medicine.’”

Tripping Over The Truth

Interestingly, last week I watched an amazing interview by Regina Meredith on the Gaia TV network. Author Travis Christofferson was discussing his book, Tripping Over the Truth: The Metabolic Theory of Cancer. Briefly, Tripping over the Truth follows the story of cancers proposed metabolic origin to modern laboratories around the world. The author takes the reader on a journey through time and science that results in an astounding connecting of the dots with profound implications. He breaks down and expounds on humanities struggle to understand the cellular events that conspire to form malignancy. By the end of the interview I arrived at a conclusion that challenged everything I thought I knew about the disease. I felt that possibly the reason for the failed war against cancer stems from a flawed paradigm that categorizes cancer as an exclusively genetic disease! What if it’s not?!!Christofferson also brought up, Tissue Architecture theory (a part of an organism consisting of a large number of cells having a similar structure and function)  – which simply means the default state of any cell is cell division. “It’s what keeps a cell in check, living in the multicellular organism is the tissue architecture. So when your cells are in a healthy tissue architecture, they cooperate with the collective. But once that architecture breaks down through inflammation, through carcinogens — you then release those negative controls from the tissue architecture and cells are then off racing towards neoplasm…towards cancer.”

In my opinion Tripping Over the Truth provides a fresh and hopeful perspective. It explores the new and exciting non-toxic therapies born from the emerging metabolic theory of cancer. Therapies that may one day prove to be a turning point in the struggle against our ancient enemy.

If you know someone who has suffered or suffering from cancer you owe it to them to dig deeper and start questioning the system. You can start by picking up Tripping Over The Truth.  To find out more about Christofferson please click here  >> www.singlecausesinglecure.org/author/travisc/   to be redirected.

 

Sources:

www.medicalnewstoday.com/articles/246061.php

www.buzzsouthafrica.com/2017-world-cancer-day/

www.singlecausesinglecure.org/author/travisc/

Tags: #Books #CancerCure #TissueArchitecture #KetoGeneticDiet #Fasting #TrippingOverTheTruth

 

Comments

comments

Powered by Facebook Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>